Royce & Associates’s Alimera Sciences, Inc. ALIM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-61,125
| Closed | -$235K | – | 1235 |
|
2020
Q1 | $235K | Buy |
61,125
+15,000
| +33% | +$57.7K | ﹤0.01% | 908 |
|
2019
Q4 | $350K | Buy |
46,125
+3,333
| +8% | +$25.3K | ﹤0.01% | 925 |
|
2019
Q3 | $363K | Buy |
42,792
+5,000
| +13% | +$42.4K | ﹤0.01% | 928 |
|
2019
Q2 | $505K | Sell |
37,792
-293
| -0.8% | -$3.92K | ﹤0.01% | 906 |
|
2019
Q1 | $606K | Buy |
38,085
+16,806
| +79% | +$267K | 0.01% | 906 |
|
2018
Q4 | $229K | Buy |
21,279
+8,000
| +60% | +$86.1K | ﹤0.01% | 974 |
|
2018
Q3 | $195K | Buy |
+13,279
| New | +$195K | ﹤0.01% | 1015 |
|